calendar
897 catalysts · 3,045 8k filing · 2,029 grant · 1,000 device adverse event · 897 approval · 659 device 510k · 579 earnings
next 91 dayslessmore
MonWedFri
897 catalysts · 3,045 8k filing · 2,029 grant · 1,000 device adverse event · 897 approval · 659 device 510k · 579 earnings
no tagged catalysts yet
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: SUNSHINE. Form: TABLET. Route: ORAL
Sponsor: SUNSHINE. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INJECTION
Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA PHARMS. Form: FOR SUSPENSION. Route: ORAL
Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL
Sponsor: GILEAD SCIENCES INC. Form: CAPSULE. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: EPIC PHARMA LLC. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: ALKERMES INC. Form: TABLET. Route: ORAL
Sponsor: PLATINUM. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS
Sponsor: NOVO. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: JUBILANT GENERICS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
Sponsor: CIPLA. Form: CAPSULE. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: CMP DEV LLC. Form: SOLUTION. Route: ORAL
Sponsor: GENERAL AIR SERVICE & SUPPLY COMPANY. Form: GAS. Route: INHALATION
Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL
Sponsor: LONG GROVE PHARMS. Form: GEL, METERED. Route: TRANSDERMAL
Sponsor: CHANGZHOU PHARM. Form: CAPSULE. Route: ORAL
Sponsor: APIL. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ORGANON. Form: TABLET. Route: ORAL